Impact News +++ LECTRA: Q3 and First Nine Months of 2025 Financial Report available (GlobeNewswire EN) +++ LECTRA Aktie -7,64%

PACIFIC BIOSCIENCES Aktie

>Aktienkurs

1.75 EUR +2.5% (Tradegate)

Ask: 1.7632 EUR / 5700 Stück

Bid: 1.7112 EUR / 5900 Stück

Tagesumsatz: 22309 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>Performance

1 Woche: +13,4%

1 Monat: +63,4%

3 Monate: +20,9%

6 Monate: +76,0%

1 Jahr: +1,4%

laufendes Jahr: -3,1%

>PACIFIC BIOSCIENCES Aktie

Name:

PACIFIC BIOSCIENCES

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US69404D1081 / A1C3EQ

Symbol/ Ticker:

P09 (Frankfurt) / PACB (NASDAQ)

Kürzel:

FRA:P09, ETR:P09, P09:GR, NASDAQ:PACB

Index:

Webseite:

http://www.pacificbioscie..

Profil:

Pacific Biosciences of California, Inc. is a biote..
>Volltext..

Marktkapitalisierung:

538.85 Mio. EUR

Unternehmenswert:

864.83 Mio. EUR

Umsatz:

134 Mio. EUR

EBITDA:

-141.6 Mio. EUR

Nettogewinn:

-450.77 Mio. EUR

Gewinn je Aktie:

-1.53 EUR

Schulden:

600.17 Mio. EUR

Liquide Mittel:

47.3 Mio. EUR

Operativer Cashflow:

-128.36 Mio. EUR

Bargeldquote:

5.27

Umsatzwachstum:

-24.84%

Gewinnwachstum:

-19.26%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

PACIFIC BIOSCIENCES, PACIFIC BIOSCIENCE

Letzte Datenerhebung:

29.10.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 300.37 Mio. St.

Frei handelbar: 88.65%

Leerverk. Aktien: 11.49%

Rückkaufquote: -0.44%

Mitarbeiter: 575

Umsatz/Mitarb.: 0.23 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 6.59%

Bewertung:

KGV: -

KGV lG: -

KUV: 4.04

KBV: 9.45

PEG-Ratio: -0.02

EV/EBITDA: -

Rentabilität:

Bruttomarge: -215.73%

Gewinnmarge: -336.4%

Operative Marge: -364.72%

Managementeffizenz:

Gesamtkaprendite: -44.98%

Eigenkaprendite: -189.52%

>Peer Group

Es sind 596 Aktien bekannt.

>Chart & Kurs - NASDAQ

>Alle News

29.10.25 - 00:45	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
	Pacific Biosciences of California (PACB) concluded the recent trading session at $1.97, signifying a -5.74% move from its prior day's close....

22.10.25 - 01:45	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
	Pacific Biosciences of California (PACB) reached $1.9 at the closing of the latest trading day, reflecting a -4.04% change compared to its last close....

15.10.25 - 01:45	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
	In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.59, marking a -1.85% move from the previous day....

07.10.25 - 01:45	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
	In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.52, marking a +2.01% move from the previous day....

23.09.25 - 01:45	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
	In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.29, indicating a +1.57% shift from the previous trading day....

13.09.25 - 01:45	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks)
	In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.17, denoting a -7.14% move from the preceding trading day....

21.08.25 - 02:01	Insiderhandel: Vorstand verkauft Aktien von Pacific Biosciences of California im Wert von 35182 USD (Insiderkauf)
	Van Oene Mark - Vorstand - Tag der Transaktion: 2025-08-18...

08.08.25 - 03:15	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	The headline numbers for Pacific Biosciences (PACB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

08.08.25 - 02:30	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
	Pacific Biosciences (PACB) delivered earnings and revenue surprises of +27.78% and +9.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.08.25 - 22:12	Pacific Biosciences of California Non-GAAP EPS of -$0.13 beats by $0.04, revenue of $39.8M beats by $3.33M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.25 - 01:45	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
	Pacific Biosciences of California (PACB) reached $1.54 at the closing of the latest trading day, reflecting a -6.1% change compared to its last close....

18.07.25 - 01:45	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
	Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, reflecting a -6.71% change compared to its last close....

11.07.25 - 01:45	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
	The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.5, representing a +1.35% change from its previous close....

08.07.25 - 19:45	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here′s What You Should Know (Zacks)
	Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy)....

01.07.25 - 01:45	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
	The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.24, representing a -3.88% change from its previous close....

13.06.25 - 01:45	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
	Pacific Biosciences of California (PACB) closed at $1.18 in the latest trading session, marking a +1.72% move from the prior day....

29.05.25 - 19:45	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks)
	Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

22.05.25 - 02:01	Insiderhandel: Vorstand verkauft Aktien von Pacific Biosciences of California im Wert von 5200 USD (Insiderkauf)
	Farmer, Michele - Vorstand - Tag der Transaktion: 2025-05-19...

15.05.25 - 16:33	Where Pacific Biosciences Stands With Analysts (Benzinga)
	Latest Ratings for PACB DateFirmActionFromTo Feb 2022Canaccord GenuityMaintainsBuy Sep 2021Canaccord GenuityInitiates Coverage OnBuy Aug 2021Morgan StanleyMaintainsEqual-Weight View More Analyst Ratings for PACB View the Latest Analyst Ratings read more...

09.05.25 - 04:45	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
	While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Vor einem Fremden tue nichts Heimliches, denn du weißt nicht, was er davon an den Tag bringt. - Altes Testament: Buch Jesus Sirach

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram